NASDAQ:CVKD | Free Cash Flow | Cadrenal Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3M
2025-12-31-$2.57M$0.00-$2.57M
2025-03-31-$4.65M$3,251.00-$4.65M
2024-12-31-$1.79M
2024-03-31-$1.84M
2023-12-31-$694,445.00$0.00-$694,445.00
2023-03-31-$1.41M
2022-12-31-$290,216.00$1.00-$290,217.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$12.6M$5,104.00-$12.61M
2024-12-31-$7.36M$6,537.00-$7.36M
2023-12-31-$3.53M$3,254.00-$3.53M
2022-12-31-$1.2M$2,279.00-$1.21M